Dana Goldman, PhD - USC Schaeffer
Dana P. Goldman is a University Professor of Public Policy, Pharmacy, and Economics at the University of Southern California and the Leonard D. Schaeffer| USC Schaeffer
Dana P. Goldman is a University Professor of Public Policy, Pharmacy, and Economics at the University of Southern California and the Leonard D. Schaeffer| USC Schaeffer
To harness the full potential of new medical technologies, a new white paper calls for significant FDA reforms to streamline clinical trials, provide greater certainty for innovators and speed game-changing treatments to more patients. - September 11, 2025| USC Schaeffer
We propose a set of recommended actions FDA should take to accelerate development of transformative medical technologies and enhance patient access. - September 11, 2025| USC Schaeffer
Rosalie Liccardo Pacula holds the Elizabeth Garrett Chair in Health Policy, Economics & Law in the Health Policy and Management Department at the USC| USC Schaeffer
Establishing value-based drug prices using GRACE costs about the same as using traditional cost-effectiveness analysis. - September 5, 2025| USC Schaeffer
Even as policymakers have made it much easier to prescribe buprenorphine, a new Schaeffer Center study finds most pharmacies still aren't carrying the treatment. - September 2, 2025| USC Schaeffer
